Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy
- 1 January 2003
- journal article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 75 (1), 231-236
- https://doi.org/10.1016/s0003-4975(02)04350-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mediastinal Lymph Node Sampling Following Positron Emission Tomography With Fluorodeoxyglucose Imaging in Lung Cancer StagingChest, 2001
- Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -Pneumologie, 2001
- Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancerEuropean Respiratory Journal, 1999
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Regional Lymph Node Classification for Lung Cancer StagingChest, 1997
- Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancerEuropean Respiratory Journal, 1996
- Mediastinal staging of non-small-cell lung cancer with positron emission tomography.American Journal of Respiratory and Critical Care Medicine, 1995
- Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)The Journal of Thoracic and Cardiovascular Surgery, 1995
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- A Simple Cervicomediastinal Exploration for Tissue Diagnosis of Intrathoracic DiseaseNew England Journal of Medicine, 1954